Shares of NuScale Power Corporation (NYSE: SMR) declined 4.6% on Friday, as market participants grappled with the stark contrast between the company's near-$4 billion market capitalization and its minimal revenue generation. The stock closed at $9.29, down 4.62%, with 37.8 million shares changing hands—112% of the average daily volume over the past 65 days.
The sell-off was part of a broader downturn in the nuclear energy sector, with peers Oklo Inc. (OKLO) falling 5.64%, Nano Nuclear Energy (NNE) dropping 6.60%, and Cameco Corporation (CCJ) sliding 5.94%. This sector-wide weakness suggests a macro-driven correction rather than company-specific news, as rising Treasury yields following Federal Reserve Chair Kevin Warsh's inflation warning put pressure on long-duration growth stocks.
NuScale's valuation metrics remain striking. The company's $3.99 billion market value equates to roughly 373 times its trailing twelve-month revenue of $10.7 million. This premium is largely predicated on anticipated future reactor agreements and the successful commercialization of its small modular reactor (SMR) technology, which has received design approval from the U.S. Nuclear Regulatory Commission.
However, the financial picture is sobering. Second-quarter revenue plummeted to approximately $75,000, following the conclusion of engineering activities in Romania. The company has accumulated net losses of about $416 million, and spending continues to outpace order intake. Research expenses rose by $6.6 million year-over-year, while administrative costs increased by $4.4 million, according to company filings.
A mitigating factor is the company's substantial cash position. As of June 30, NuScale held $1.9 billion in cash and investments, representing 48% of its equity value. This liquidity cushion provides a runway for continued development, but it also raises questions about the sustainability of a business that has yet to secure a single commercial reactor order.
Chief Executive John Hopkins has emphasized progress toward commercial readiness, noting involvement from over 60 specialized suppliers and the completion of more than 30 agreements. The company's technology is advanced: each authorized NuScale Power Module generates 77 megawatts, with a 12-module plant capable of delivering up to 924 megawatts.
Yet commercial validation remains elusive. NuScale and its partner ENTRA1 are still in discussions with the Tennessee Valley Authority regarding a power purchase agreement, while the RoPower project in Romania awaits satisfaction of outstanding requirements. These delays prolong the timeline to meaningful revenue generation and increase the risk of further dilution.
Wall Street remains cautiously optimistic, with 18 analysts assigning a Hold rating and an average price target of $12.63, implying a 36% upside from current levels. Price targets range from $6 to $20, reflecting significant uncertainty about the company's trajectory.
Key risks include potential contract delays, escalating construction costs, customer financing hurdles, regulatory clearances, and the possibility of additional share offerings that could dilute existing shareholders. The next financial update is scheduled for November 5, when investors will focus on confirmed orders, partner contributions, and cash flow—factors that are likely to carry more weight than technical milestones.
